Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.
Wang, Yi-Chun
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study. [electronic resource] - Medicine Jan 2016 - e2487 p. digital
Publication Type: Journal Article; Observational Study
1536-5964
10.1097/MD.0000000000002487 doi
Aged
Calcium Channel Blockers--adverse effects
Cytochrome P-450 CYP3A Inhibitors--adverse effects
Drug Interactions
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Male
Middle Aged
Retrospective Studies
Risk Assessment
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study. [electronic resource] - Medicine Jan 2016 - e2487 p. digital
Publication Type: Journal Article; Observational Study
1536-5964
10.1097/MD.0000000000002487 doi
Aged
Calcium Channel Blockers--adverse effects
Cytochrome P-450 CYP3A Inhibitors--adverse effects
Drug Interactions
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Male
Middle Aged
Retrospective Studies
Risk Assessment